PAHC · CIK 0001069899 · operating
Phibro Animal Health Corporation develops and manufactures pharmaceuticals, vaccines, and nutritional products for animal agriculture and companion animals. The company's product portfolio includes antibacterials, anticoccidials, nutritional supplements, and vaccine adjuvants designed to support animal health, performance, food safety, and welfare. It also produces trace mineral formulations containing zinc, copper, manganese, and iron for livestock feed fortification, and develops autogenous and conventionally licensed vaccine products for animal vaccine manufacturers. Additionally, the company supplies specialty ingredients for personal care, industrial chemical, and chemical catalyst applications.
The company operates through three primary segments: Animal Health, Mineral Nutrition, and Performance Products. Its Animal Health segment serves integrated poultry, swine, and cattle producers as well as aquaculture operations. Products are distributed through local sales offices, commercial animal feed manufacturers, wholesalers, and distributors across multiple channels.
Phibro Animal Health operates with approximately 2,475 full-time employees and maintains a global footprint spanning the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. The company was incorporated in Delaware in 1946 and is headquartered in Teaneck, New Jersey.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $1.19 | $1.19 | +1883.3% | |
| 2024 | $0.06 | $0.06 | -92.6% | |
| 2023 | $0.81 | $0.81 | -33.1% | |
| 2022 | $1.21 | $1.21 | -9.7% | |
| 2021 | $1.34 | $1.34 | +61.4% | |
| 2020 | $0.83 | $0.83 | -38.5% | |
| 2019 | $1.35 | $1.35 | -16.1% | |
| 2018 | $1.61 | $1.61 | +0.0% | |
| 2017 | $1.61 | $1.63 | -22.2% | |
| 2016 | $2.07 | $2.11 | +696.2% | |
| 2015 | $0.26 | $0.27 | — | |
| 2014 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-06-30 | 2025-08-27 | 0001558370-25-011776 | SEC ↗ |
| 2024-06-30 | 2024-08-28 | 0001558370-24-012517 | SEC ↗ |
| 2023-06-30 | 2023-08-30 | 0001558370-23-015357 | SEC ↗ |
| 2022-06-30 | 2022-08-24 | 0001558370-22-013940 | SEC ↗ |
| 2021-06-30 | 2021-08-25 | 0001104659-21-109354 | SEC ↗ |
| 2020-06-30 | 2020-08-26 | 0001104659-20-098687 | SEC ↗ |
| 2019-06-30 | 2019-08-27 | 0001144204-19-041832 | SEC ↗ |
| 2018-06-30 | 2018-08-27 | 0001144204-18-046489 | SEC ↗ |
| 2017-06-30 | 2017-08-30 | 0001571049-17-007711 | SEC ↗ |
| 2016-06-30 | 2016-08-29 | 0001571049-16-017853 | SEC ↗ |
| 2015-06-30 | 2015-09-10 | 0001571049-15-007431 | SEC ↗ |
| 2014-06-30 | 2014-09-18 | 0001571049-14-004664 | SEC ↗ |
| 2005-06-30 | 2005-09-28 | 0000950123-05-011600 | SEC ↗ |
| 2004-06-30 | 2004-09-28 | 0000891092-04-004563 | SEC ↗ |
| 2003-06-30 | 2003-09-29 | 0000950123-03-010897 | SEC ↗ |
| 2002-06-30 | 2002-10-25 | 0000891092-02-001196 | SEC ↗ |
| 2001-06-30 | 2001-10-11 | 0000891092-01-500762 | SEC ↗ |